ADAM10 as a Therapeutic Target for Cancer and Inflammation

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|20|2288-2299

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.20, 2009-07, pp. : 2288-2299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ADAM10 as a Target for Anti-Cancer Therapy

By  

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 1, 2008-02 ,pp. : 2-8

Bentham Science Publishers

Access to resources Recommend Favorite

ADAM Proteins- Therapeutic Potential in Cancer

By  

Current Cancer Drug Targets, Vol. 8, Iss. 8, 2008-12 ,pp. : 720-732

Bentham Science Publishers

Access to resources Recommend Favorite

ADAM33: a novel therapeutic target for asthma

By Powell Robert M   Hamilton Lynnsey M   Holgate Stephen T   Davies Donna E   Holloway John W  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 4, 2003-08 ,pp. : 485-494

Informa Healthcare

Access to resources Recommend Favorite

ADAM17 as a Therapeutic Target in Multiple Diseases

By  

Current Pharmaceutical Design, Vol. 15, Iss. 20, 2009-07 ,pp. : 2319-2335

Bentham Science Publishers

Access to resources Recommend Favorite

Hydrogen sulfide as a therapeutic target for inflammation

By Rivers Jack R   Badiei Alireza   Bhatia Madhav  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 439-449

Informa Healthcare

Access to resources Recommend Favorite